Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 8Gynecologic 7Breast 6Genitourinary 5Gastrointestinal 5Sarcoma 3Other solid neoplasm 3Other hematologic neoplasm 3Lymphoid 3Head & Neck 3Tumor-Agnostic 1Plasma cell 1Other 1Endocrine 1Dermatologic 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 2Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Restraint, Physical × Other solid neoplasm × Clear all
NCT07225920 2026-04-08

PGA

Wake Forest University Health Sciences

Phase NA Enrolling by invitation
216 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06582030 2024-09-03

Stop Addiction Stigma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
93 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT01005693 2013-05-15

Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment

National Cancer Institute (NCI)

Phase NA Unknown
300 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡